Susquehanna International Group, LLP 89bio, Inc. Call Options Transaction History

Susquehanna International Group, LLP

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$7.36 - $9.66 $39,744 - $52,164	-5,400 Reduced 12.03%	39,500 $292,000
Q2 2024 Aug 15, 2024	SELL	$7.31 - $10.9 $922,522 - $1.38 Million	-126,200 Reduced 73.76%	44,900 $359,000
Q1 2024 May 07, 2024	BUY	$8.13 - $13.77 $333,330 - $564,570	41,000 Added 31.51%	171,100 $1.99 Million
Q4 2023 Feb 14, 2024	SELL	$6.66 - $16.03 $1.65 Million - $3.96 Million	-247,300 Reduced 65.53%	130,100 $1.45 Million
Q3 2023 Nov 14, 2023	BUY	$15.06 - $19.41 $4.73 Million - $6.1 Million	314,400 Added 499.05%	377,400 $5.83 Million
Q2 2023 Aug 11, 2023	SELL	$14.15 - $22.03 $3.5 Million - $5.45 Million	-247,500 Reduced 79.71%	63,000 $1.19 Million
Q1 2023 May 16, 2023	BUY	$10.48 - $16.94 $1.08 Million - $1.74 Million	102,900 Added 49.57%	310,500 $4.73 Million
Q4 2022 Feb 14, 2023	BUY	$5.52 - $12.73 $234,047 - $539,752	42,400 Added 25.67%	207,600 $2.64 Million
Q3 2022 Nov 14, 2022	BUY	$3.02 - $7.0 $498,904 - $1.16 Million	165,200 New	165,200 $957,000
Q4 2021 Feb 14, 2022	SELL	$11.15 - $19.66 $33,450 - $58,980	-3,000 Reduced 20.27%	11,800 $154,000
Q3 2021 Nov 15, 2021	BUY	$14.91 - $21.31 $37,275 - $53,275	2,500 Added 20.33%	14,800 $290,000
Q2 2021 Aug 11, 2021	SELL	$17.42 - $28.0 $6,968 - $11,200	-400 Reduced 3.15%	12,300 $230,000
Q1 2021 May 17, 2021	BUY	$20.22 - $26.73 $256,794 - $339,471	12,700 New	12,700 $301,000

158

108M

73.6K

1.19M

Ticker ETNB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,484,500
Market Cap $371M
Description
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.